Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 6Breast Neoplasms 5Hematologic Neoplasms 4Colorectal Neoplasms 4Anatomic Stage I Breast Cancer AJCC v8 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Breast Carcinoma In Situ 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Neoplasms 2Multiple Myeloma 2Lymphoma 2Head and Neck Carcinoma 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2COVID-19 2Uveal Melanoma 1Urologic Neoplasms 1Urologic Diseases 1Smoking 1Resectable Colorectal Carcinoma 1Renal Insufficiency, Chronic 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Oligometastatic Malignant Solid Neoplasm 1Leukemia, Myeloid, Acute 1Hypogonadism 1

Interventions

testosterone 17 beta-cypionate 1Urinary Diversion 1Testosterone Propionate 1Standard of Care 1Radiosurgery 1Practice Guidelines as Topic 1Methyltestosterone 1Immune Checkpoint Inhibitors 1Cystectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Urologic Diseases × Practice Guidelines as Topic × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡